Deutsche Bank
ORMP icon

Deutsche Bank’s Oramed Pharmaceuticals ORMP Stock Holding History

Deutsche Bank’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-21,402
Closed -$185K – 4267
2022
Q1 		$185K Sell
21,402
-2,004
-9% -$20.5K ﹤0.01% 3312
2021
Q4 		$334K Buy
23,406
+4,679
+25% +$97.8K ﹤0.01% 3081
2021
Q3 		$411K Buy
18,727
+1,578
+9% +$26.9K ﹤0.01% 3173
2021
Q2 		$229K Buy
+17,149
New +$196K ﹤0.01% 3707
2020
Q1 		– Sell
-3,103
Closed -$15K – 4677
2019
Q4 		$15K Buy
+3,103
New +$11.6K ﹤0.01% 4385
2019
Q2 		– Sell
-10,527
Closed -$38K – 5451
2019
Q1 		$38K Buy
+10,527
New +$34.8K ﹤0.01% 4643
2018
Q4 		– Sell
-23,345
Closed -$114K – 5339
2018
Q3 		$114K Buy
23,345
+5,745
+33% +$29.8K ﹤0.01% 4453
2018
Q2 		$131K Sell
17,600
-7,314
-29% -$53.1K ﹤0.01% 4448
2018
Q1 		$162K Sell
24,914
-9,694
-28% -$74.8K ﹤0.01% 4296
2017
Q4 		$311K Buy
34,608
+5,174
+18% +$49.5K ﹤0.01% 3825
2017
Q3 		$292K Buy
29,434
+29,429
+588,580% +$254K ﹤0.01% 3689
2017
Q2 		$0 Hold
5
– – ﹤0.01% 5060
2017
Q1 		$0 Hold
5
– – ﹤0.01% 5055
2016
Q4 		$0 Sell
5
-5,000
-100% -$32.6K ﹤0.01% 5032
2016
Q3 		$36K Buy
5,005
+3,942
+371% +$30.6K ﹤0.01% 4334
2016
Q2 		$8K Sell
1,063
-437
-29% -$3.72K ﹤0.01% 4940
2016
Q1 		$9K Buy
1,500
+1,405
+1,479% +$9.41K ﹤0.01% 4851
2015
Q4 		$0 Buy
+95
New +$720 ﹤0.01% 5371

Other funds holding ORMP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank's ORMP Position: Q2 2022 in Review

Deutsche Bank sold out of Oramed Pharmaceuticals (ORMP) in Q2 2022, closing a stake of 21,402 shares — an estimated $185K sold.

Deutsche Bank first reported a position in ORMP in Q4 2015 and held it in 18 quarters. The position peaked at $411K in Q3 2021. 88 funds tracked by Wall St. Rank hold ORMP as of Q2 2022.

  • Deutsche Bank reported no remaining Oramed Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 21,402 Oramed Pharmaceuticals shares in Q2 2022, an estimated $185K.
  • Deutsche Bank first reported a position in Oramed Pharmaceuticals in Q4 2015 and held it in 18 quarters.
  • Deutsche Bank's Oramed Pharmaceuticals position peaked at $411K in Q3 2021.
  • 88 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.